Background-Elevated left ventricular filling pressure is a cardinal feature of heart failure with preserved ejection fraction.
D yspnea is a common symptom, affecting up to half of patients in the inpatient setting and one quarter of patients in the ambulatory setting. 1 Dyspnea may be caused by cardiac, pulmonary, hematologic, neuropsychiatric, or neuromuscular diseases. Among patients with dyspnea and normal left ventricular ejection fraction (LVEF), pulmonary function, and oxygen carrying capacity, the diagnosis of heart failure with preserved ejection fraction (HFpEF) is particularly challenging. Because cardiac structural and functional changes in HFpEF are more subtle and less specific than in heart failure with reduced LVEF, the demonstration of increased left ventricular filling pressure (LVFP) is central to establishing this diagnosis. 2 The invasive assessment of LVFP is usually done during right heart catheterization (RHC) by measurement of pulmonary arterial wedge pressure (PAWP). Transthoracic echocardiography can be used to noninvasively estimate LVFP. Several echocardiographic measures have been used, 3 but the ratio of the peak early mitral inflow velocity (E) over the early diastolic mitral annular velocity (e′) has gained wide acceptability in routine clinical practice. 4 Although integration of multiple echocardiographic measures is always preferred, the E/e′ ratio is often used by itself to appraise LVFP because of the relative ease of acquisition, calculation, and interpretation. The E/e′ ratio has been endorsed by professional guidelines as a surrogate parameter of LVFP in the diagnostic work-up of HFpEF. 5 In theory, a decrease in LV preload (a major determinant of LVFP) will result in a lower atrial-to-LV diastolic pressure gradient and lower E-wave velocity, without significantly affecting e′, which is considered to be relatively independent of pressure-flow gradients. 6 Despite its widespread use, conflicting data have been reported about its accuracy and its ability to track changes in LVFP. 4, [7] [8] [9] [10] Therefore, we aimed to study the accuracy of E/e′ to estimate and track changes in LVFP, as well as to identify elevated LVFP consistent with HFpEF in patients with unexplained dyspnea and a preserved LVEF.
Methods

Subjects and Study Design
We studied sequential patients with dyspnea of indeterminate cause referred to the Dyspnea Clinic at Brigham and Women's Hospital between May 2013 and June 2014. All patients underwent resting supine and upright invasive hemodynamic evaluations. Patients with LVEF <50%, more than mild valvular disease, prosthetic mitral valve, and atrial fibrillation were excluded from this analysis. The Partners Human Research Committee approved this study and waived the requirement for informed consent.
Invasive Hemodynamic Study
A flow-directed, balloon-tipped, 4-port pacing pulmonary artery catheter (Edwards Lifesciences, Irvine, CA) was placed into the pulmonary artery, with ultrasound and fluoroscopic guidance. A second catheter was inserted into the radial artery using a 20-gauge intravenously or 5-French sheath. End expiratory systemic arterial, right atrial, right ventricular, pulmonary artery pressures, and PAWP were measured using a hemodynamic monitoring system (Xper Cardio Physiomonitoring System, Philips, Andover, MA) calibrated before each study. The pressure transducer was leveled using as references the mid axillary line (supine) and 5 cm below the axillary fold (upright). Cardiac output was determined by assumed Fick or thermodilution methods during supine RHC, and true Fick method with direct measurement of VO 2 , arterial and mixed venous O 2 content, during upright assessments.
Echocardiography
Supine transthoracic echocardiography was performed before patients underwent RHC (time interval <1 hour). After catheterization, upright transthoracic echocardiography was performed with the patient seated resting on the cycle ergometer simultaneously with the invasive hemodynamic measurements. All quantitative echocardiographic measurements were performed by a single reader (M.S.) blinded to invasive hemodynamic data, using a computerized off-line analysis station as previously described. 11 Peak early diastolic tissue velocity (e′) was measured at the septal and lateral mitral annulus. Mitral inflow velocity was assessed by pulsed wave Doppler from the apical 4-chamber view, positioning the sample volume at the tip of the mitral leaflets. Deceleration time of the E wave was measured as the interval from the peak E wave to its extrapolation to the baseline. E/e′ ratio was calculated as E wave divided by e′ velocities. LV mass was estimated from LV linear dimensions and indexed to body surface area as recommended by ASE guidelines. 12 LV hypertrophy was defined as LV mass indexed to body surface area (LV mass index) >115 g/m 2 in men or >95 g/m 2 in women. LV volumes were estimated by the modified Simpson method using the apical 4-and 2-chamber views, and LVEF was derived from volumes in the standard manner. LA volume was estimated by the method of disks using apical 4and 2-chamber views at an end-systolic frame preceding mitral valve opening and was indexed to body surface area to derive LA volume index. Measurements were performed in triplicate and the average value used for analysis. Intraobserver reproducibility was assessed in 20 studies randomly selected with the following results. E wave: correlation coefficient 0.99, coefficient of variation 4%; septal e′: correlation coefficient 97%, coefficient of variation 4%; and lateral e′: correlation coefficient 98%, coefficient of variation 5%. For the purposes of generalizability, interobserver reproducibility was assessed in the same 20 studies with the following results. E wave: correlation coefficient 0.94, coefficient of variation 6%; septal e′: correlation coefficient 0.98, coefficient of variation 7%; and lateral e: correlation coefficient 97%, coefficient of variation: 8%.
Statistical Analysis
Continuous variables are expressed as mean±SD for normally distributed variables or median and interquartile range for non-normally distributed variables. Categorical variables are expressed as number of subjects and proportion (n [%]). Comparisons between groups were ACEi indicates angiotensin-converting enzyme inhibitor; ARB, angiotensin II receptor blockers; ASA, acetylsalicylic acid; BMI, body mass index; BSA, body surface area; CAD, coronary artery disease; CCB, calcium-channel blockers; CKD, chronic kidney disease (eGFR <60 mL/min per m 2 ); eGFR, estimated glomerular filtration rate (calculated using Cockcroft-Gault equation); LAVi, left atrium volume index; LV, left ventricular; LVESVi, LV end-systolic volume index; LVH, LV hypertrophy; LVEDVi, LV end-diastolic volume index; and LVEF, LV ejection fraction. performed using 2-sided parametric or nonparametric tests (unpaired or paired t or Wilcoxon rank sums) for normally and non-normally distributed data respectively. Fisher exact test was used to compare proportions. Univariate linear regression analysis was performed to model an equation of the relationship between E/e′ ratio and PAWP. Univariate logistic regression was used to study the association between E/e′ ratio the dichotomous variable of elevated LVFP (PAWP≥15 mm Hg). For each analysis, separate univariate regression models were generated each of the following predictor variables: lateral E/e′ ratio, septal E/e′ ratio, and average E/e′ ratio. To further assess the potential for E/e′ ratio to identify elevated LVFP, receiver-operating characteristic curve analyses were performed. Correlations between those variables were determined using Pearson or Spearman correlation, as appropriate. Bland-Altman analysis was used to assess agreement between noninvasive and invasive variables. Two supplemental analyses were performed. To assess the impact of missing data on our findings, we performed all analyses restricted to the population of patients with complete data for supine and upright PAWP and E/e′ ratio. In a second supplemental analysis, to assess the potential impact of an outlier value, we repeated the analysis excluding this outlier value. A 2-sided P<0.05 was considered significant. Statistical analysis was performed using Stata software Version 12.1 (Stata Corp LP, College Station, TX).
Results
Studied Sample
Of a total of 140 subjects, we excluded 22 because of: LVEF<50% (n=3), more than mild valvular disease (n=13), valvular prosthesis (n=4), and atrial fibrillation (n=2). Of the remaining 118 patients included in this analysis, 70% were women and the median age was 57 years (first to third quartile, 40-70 years; Table 1 ). Mean body mass index was 27.5±6.5 kg/m 2 , and 25% of patients were obese (defined as body mass index≥30 kg/m 2 ). The most prevalent comorbidity was hypertension (46%). Average LV mass index was 64±19 g/m 2 , and LV hypertrophy was present in 23% of patients. LVEF was normal (63±8%) and supine invasive hemodynamics revealed normal average cardiac index (3.0±0.6 L/min per m 2 ), with a mean PAWP of 12±5 mm Hg. Twenty-six (22%) had a supine PAWP >15 mm Hg. Echocardiographic data are summarized in Tables 1 and 2 . Mean E/A ratio was 1.2±0.5, and e′ septal (8.7±2.8 cm/s) was lower than e′ lateral (11.9±4.3 cm/s; P<0.001). A indicates peak late mitral inflow velocity; BP, blood pressure; CI, cardiac index; DT, deceleration time; E, peak early mitral inflow velocity; e′, peak early diastolic mitral annular velocity; HR, heart rate; LAVi, left atrium volume index; LVEDSi, left ventricular endsystolic volume index; LVEDVi, left ventricular end-diastolic volume index; LVEF, left ventricular ejection fraction; MAP, mean arterial pressure; PAWP, pulmonary artery wedge pressure; and SVR, systemic vascular resistance. July 2015
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PAWP modestly correlated with E/e′ septal (r=0.41; P<0.001), lateral (r=0.30; P<0.001), and average (r=0.36; P<0.001; Table 3 ; Figure 1 ). E/e′ refers to average E/e′ throughout the remainder of this article unless specifically noted. E/A ratio was even more modestly correlated with PAWP (r=0.21; P=0.04); no correlation was found between deceleration time and PAWP (r=−0.06; P=0.57). Using supine average E/e′ to predict supine PAWP, the linear regression model was: PAWP=0.44×E/e′ average+7.2 (n=88; for the slope: P=0.001; 95% confidencce interval [CI] for β coefficient for E/e′ was 0.20-0.68). We computed the predicted PAWP estimated by this linear regression equation, and used the Bland-Altman method to quantify the agreement of the predicted PAWP with the invasively measured PAWP. There was no bias (mean, 0 mm Hg; 95% CI, −0.8; 0.8), and the limits of agreement were wide (−7.7 to 7.7 mm Hg; Figure 1 ).
Twenty-two percent (n=26) of the study cohort has a supine RHC PAWP>15 mm Hg. 13 In a logistic regression model, average E/e′ ratio was not significantly predictive of elevated LVFP (OR, 1.09; P, 0.22; 95% CI, 0.95-1.27), with a receiver-operating characteristic area of 0.65 (95% CI, 0.50-0.79). Although the mean PAWP was higher among those with an average E/e′ ≥13 compared with <13 (14±6 versus 11±4 mm Hg respectively, P=0.001), an E/e′ average ≥13 had a sensitivity of 6% and a specificity of 90% to identify elevated LVFP. Similarly, the receiver-operating characteristic areas for E/e′ septal and lateral were 0.67 (95% CI, 0.53-0.81) and 0.62 (95% CI, 0.46-0.78), respectively. An E/e′ septal ≥15 had a sensitivity of 6% and a specificity of 92%; an E/e′ lateral ≥12 had a sensitivity of 13% and a specificity of 92% to discriminate patients with elevated LVFP.
Positional Changes in Hemodynamic and Echocardiographic Measures: Supine to Upright
There was a decrease in cardiac index (−0.3±0.9 L/min per m 2 ) and PAWP (−5±4 mm Hg) from supine to upright position ( Table 2 ). Mean arterial pressure increased modestly (+4±12 mm Hg; P<0.001), as did systemic vascular resistance (+372±585 dyne . s/cm 5 ; P<0.001) and heart rate (+8±12 beats per minute; P<0.001). Both LV diastolic and systolic volumes decreased, with a mild decrease in LVEF ( Table 2) .
Despite the significant decrease of PAWP, no significant differences were found between supine and upright E/e′ ratio ( Table 2 ). We found no correlation between change in E/e′ (septal, lateral, or average) and PAWP (Table 3; Figure 2 ). In fact, 46% (23/50) of patients had a directionally discordant change of E/e′ when compared with PAWP (Table 4- Figure 2 ).
Discussion
Supine E/e′ ratio had a significant, although modest, correlation with PAWP, but demonstrated poor accuracy in estimating PAWP evidenced by the wide limits of agreement in Bland-Altman analysis. Concordantly, the recommended E/e′ ratio cut offs performed poorly in identifying elevated LVFP. Furthermore, change in E/e′ ratio from supine to upright position did not reliably track changes in PAWP, as both E and e′ were significantly affected by hemodynamic changes. In fact, half of the studied patients had a directionally opposite change in E/e′ compared with PAWP, indicating the erratic response of this noninvasive index to load changes associated with the upright position.
Although several previous studies have compared noninvasive (echocardiography-based) estimates of LVFP with invasive data (RHC), our study is one of the largest and-to our knowledge-one of the first to investigate this question in a population of patients with unexplained dyspnea, in whom assessment of LVFP is particularly important for diagnostic purposes. Consistent with previous studies using this methodology, we found a significant correlation between supine E/e′ ratio and PAWP, 14, 15 with a comparable predictive equation based on linear regression modeling. 14, 16, 17 However, correlative measurements provide little information about the agreement between supine E/e′ ratio and PAWP. Using Bland-Altman analysis, we found wide limits of agreement between predicted PAWP based on the supine E/e′ ratio and invasively measured PAWP. This indicates a large, clinically significant difference in LVFP estimation when done by these 2 methods. In addition, E/e′ ratio did not accurately identify patients with PAWP >15 mm Hg, and the recommended E/e′ cut offs had a low sensitivity to identify elevated LVFP (Figure 3) .
Change in E/e′ ratio did not correlate with change in PAWP. The mean E/e′ ratio was higher on average in the upright position compared with supine, whereas PAWP was significantly lower. This is concordant with a previous study 18 and was explained by a more pronounced decrease of e′ than E wave from supine to upright. The 17% decrease in E-wave velocity reflects a reduced transmitral pressure gradient, which may result from either a lower left atrial pressure or a higher proto-diastolic LV pressure. The e′ average demonstrated a 28% decrease with position change from supine to upright, with comparable reductions in both e′ septal and e′ lateral. Together with previous studies [19] [20] [21] that used different interventions to induce changes in LV preload, these findings clearly demonstrate that e′ is not load-independent. This preload dependence may be more pronounced in patients with a compliant myocardium, which may be more susceptible to changes in external load than a stiff myocardium. 22 There are several mechanisms that may account for this. First, reduced LV preload because of decreased venous return may influence e′ by decreasing ventricular filling during proto-diastole (rapid filling phase). 23 Decreased LV preload can also result in reduced LV systolic torsion, leading to less energy release during early diastolic elastic recoil. 24 Second, the increased systemic vascular resistance is associated with an increase of LV afterload that can influence the myocardial relaxation. 25 However, given the minor changes in systemic vascular resistance and mean arterial pressure relative to the preload changes, and the known LV diastolic tolerance to afterload when LVEF is preserved, 26 the contribution of increased afterload to the observed positional changes in e′ seems limited.
The analysis of >1 pair of measurements from each patient allows a better understanding of the individual use of E/e′ ratio, which is often overlooked when only groupderived variables are calculated from measurements at a single time point. Notably, we observed that almost half (46%) of patients had a discordant E/e′ ratio change compared with PAWP. This expresses a wide interindividual variation in the way E/e′ ratio relates with PAWP. Some previous studies have reported a significant correlation between change in E/e′ and change in PAWP in decompensated HF, heart transplant, and patients with hypertrophic cardiomyopathy, 14, 15, 17, 27 although this finding has been inconsistent. Bhella et al 16 actively manipulated LVFP of patients with HF and healthy controls. The authors described the inconsistent relation between group-and individual-derived linear regression slopes. Likewise, Mullens et al 7 did not find a correlation between E/e′ ratio and PAWP changes in decompensated patients with HF. The reasons for the discrepancy among these studies may relate to differences in patient characteristics as the presence of valvular regurgitation, interventricular dessynchrony, systolic function, and different degrees of diastolic dysfunction. Consistent with previous studies that showed a greater preload dependence of e′ in subjects with less impaired myocardial relaxation, 28, 29 we observed greater myocardial relaxation velocities in those patients with discordant changes in E/e′ and PCWP.
Differences in the study design as the small sample size of the studied groups, potential selection, and ascertainment bias may also account for that discrepancy. Together, these findings seriously question the use of this echocardiographic parameter to track LVFP changes.
This study has several limitations. TDI measurements in the upright position were missing in a subset of patients. However, the absence of differences of clinical, echocardiographic, and invasive hemodynamics measurements between patients without versus with TDI missing values argues against a systematic bias in the ascertainment of those echocardiographic images (Data Supplement). In addition, sensitivity analyses restricted to participants without missing data for supine or upright PAWP and E/e′ demonstrated consistent results with primary analysis (Data Supplement). Although upright image acquisition was simultaneous with invasive measurements, supine TDI parameters were acquired within 1 hour before the PAWP measurement. Although we cannot exclude some error because of the nonsimultaneous measurement, the brief time interval makes large changes in measures unlikely. In addition, we found better correlation on the supine than upright measurements. We used change in position (supine to upright) to examine the relationship between E/e′ ratio and LVFP changes. Although this maneuver evokes a complex cardiovascular response, the observed changes in heart rate and LV afterload surrogates suggest that the predominant change was that in LV preload, supporting the extrapolation of our results to LVFP changes occurring in other clinical scenarios. Finally, correlation analyses have disproportionate weighting of extreme outliers. We repeated our analysis excluding the observed extreme outlier (Data Supplement) and had similar findings to our primary analysis (Data Supplement). The extrapolation of our results to patients with unexplained dyspnea should be cautious, as this is a heterogeneous population comprising patients presenting a wide spectrum of structural and functional cardiac abnormalities.
Despite these limitations, our study is one of the largest with E/e′ ratio and related invasive LVFP measurements. The studied population is heterogeneous and representative of patients to whom LVFP estimation is commonly done in clinical practice to aid their diagnostic work-up. We did paired measurements for each patient, which allows us to go beyond the group mean estimates and better understand the individual response of E/e′ ratio to LVFP changes.
Conclusions
In patients with preserved LVEF referred for RHC because of unexplained dyspnea, E/e′ ratio did not accurately estimate 46% (23/50) of patients had a discordant change of E/e′ average when compared with PAWP. E indicates peak early mitral inflow velocity; e′, peak early diastolic mitral annular velocity; and PAWP, pulmonary artery wedge pressure. Figure 3 . Supine pulmonary arterial wedge pressure (PAWP) by average E/e′ ratio groups using the recommended cut off of 13.
Despite the observed differences of mean PAWP (11±4 vs 14±6 mm Hg; P=0.001), the overlap between groups is significant.
